{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Ledgewood",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98181",
      "recalling_firm": "Imprimis NJOF, LLC",
      "address_1": "1705 Route 46 Ste 6B",
      "address_2": "",
      "postal_code": "07852-9720",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S Nationwide",
      "recall_number": "D-0251-2026",
      "product_description": "Tri-Moxi+¿  (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.",
      "product_quantity": "314 boxes of 6,280 pre-filled syringes",
      "reason_for_recall": "Presence of particulate matter - Glass like particles.",
      "recall_initiation_date": "20251218",
      "center_classification_date": "20260102",
      "report_date": "20260114",
      "code_info": "Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.",
      "more_code_info": ""
    }
  ]
}